共 89 条
- [1] Kee A(2019)Value-based contracting: challenges and opportunities Am J Med Qual 34 615-617
- [2] Maio V(2018)Factors influencing the implementation of value-based contracting between pharmaceutical manufacturers and payers J Clin Pathways 4 27-30
- [3] Buyse M(2020)Is there a future for value-based contracting? Value Health 23 416-417
- [4] Carter S(2021)Impact of real-world data on market authorization, reimbursement decision & price negotiation Ther Innov Regul Sci 55 228-238
- [5] Sarnataro K(2020)Managed entry agreements: policy analysis from the European perspective Value Health 23 425-433
- [6] Cohen JP(2021)The use of innovative payments mechanisms for gene therapies in Europe and the USA Regen Med 16 405-422
- [7] Pulini AA(2018)Los contratos de riesgo compartido en el sistema nacional de salud; percepciones de los profesionales sanitarios Rev Esp Salud Pública 92 e1-e20
- [8] Caetano GM(2019)Data rich, information poor: can we use electronic health records to create a learning healthcare system for pharmaceuticals? Clin Pharmacol Ther 105 912-922
- [9] Clautiaux H(2003)Pharmacist intervention documentation in US health care systems Hosp Pharm 38 1141-1147
- [10] Vergeron L(2019)ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education-2018 Am J Health Syst Pharm 76 1038-1058